Efficacy of anakinra in a case of refractory Still disease

J Clin Rheumatol. 2008 Dec;14(6):357-8. doi: 10.1097/RHU.0b013e318188b8d8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / adverse effects
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Still's Disease, Adult-Onset / drug therapy*
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein